SCHEMBL247406

SCHEMBL247406

NC(CC1CNc2ccccc21)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.55
TDO2 P48775 1/20 0.55
CCKBR P32239 2/20 0.40
ALPI P09923 1/20 0.40
PKM P14618 1/20 0.40
PTGS1 P23219 1/20 0.40
XIAP P98170 1/20 0.40
SLC7A5 Q01650 1/20 0.40
AKT1 P31749 1/20 0.39
TACR1 P25103 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL247407 1.00 IDO1 (0.55) IDO1TDO2CCKBRALPIPKM
SCHEMBL5217962 0.87 IDO1 (0.46) IDO1TDO2CCKBRAKT1TACR1
SCHEMBL14619153 0.86 IDO1 (0.46) IDO1TDO2CCKBRALPIPKM
SCHEMBL2605810 0.85 CCKBR (0.41) IDO1TDO2CCKBRAKT1TACR1
SCHEMBL12680063 0.85 IDO1 (0.39) IDO1TDO2CCKBRAKT1TACR1
SCHEMBL13188042 0.83 IDO1 (0.41) IDO1TDO2AKT1TACR1
SCHEMBL6860568 0.83 IDO1 (0.41) IDO1TDO2AKT1TACR1
SCHEMBL14129011 0.81 AKT1 (0.37) IDO1TDO2AKT1TACR1
SCHEMBL14185276 0.81 NOD1 (0.42) IDO1TDO2PTGS1AKT1TACR1
SCHEMBL10181262 0.81 IDO1 (0.40) IDO1TDO2CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117529489-A Bicyclic peptide ligands specific for NK cells 拜斯科技术开发有限公司 2024-02-06 CN claimed
CN-105582523-B Compstatin and analogs thereof for ocular disorders 阿佩利斯制药公司 2022-04-15 CN claimed
EP-2707384-B1 CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF APELLIS PHARMACEUTICALS INC (US) 2022-04-06 EP claimed
CN-107050422-B Cell-reactive, long-acting or targeted compstatin analogs and uses thereof 阿佩利斯制药公司 2021-11-09 CN claimed
US-20180118785-A1 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-05-03 US claimed
US-20170190741-A9 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-07-06 US claimed
US-20150158913-A1 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-06-11 US claimed
EP-2311479-B1 Compstatin analogs with improved activity UNIV PENNSYLVANIA (US) 2014-07-23 EP claimed
EP-2311480-B1 Compstatin analogs with improved activity UNIV PENNSYLVANIA (US) 2013-06-26 EP claimed
EP-1549333-B1 COMPSTATIN ANALOGUES WITH IMPROVED ACTIVITY UNIV PENNSYLVANIA (US) 2011-09-21 EP claimed
EP-2311480-A1 Compstatin analogs with improved activity The Trustees of The University of Pennsylvania (US) 2011-04-20 EP claimed
JP-4614222-B2 2011-01-19 JP claimed
CN-101932325-A Ido inhibitors NEWLINK GENETICS 2010-12-29 CN claimed
EP-2227233-A2 IDO INHIBITORS Newlink Genetics (US) 2010-09-15 EP claimed
US-20100222550-A1 Compstatin analogs with improved activity NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-09-02 US claimed
WO-2009073620-A2 IDO INHIBITORS NEWLINK GENETICS (US) 2009-06-11 WO claimed
EP-1549333-A4 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY UNIV PENNSYLVANIA (US) 2008-05-28 EP claimed
EP-1549333-A1 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY The Trustees of The University of Pennsylvania (US) 2005-07-06 EP claimed
WO-2004026328-A1 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2004-04-01 WO claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed